Results
|
|
101.
|
|
|
|
102.
|
|
|
|
103.
|
Population pharmacokinetics of carboplatin in children. [electronic resource] by
- Chatelut, E
- Boddy, A V
- Peng, B
- Rubie, H
- Lavit, M
- Dezeuze, A
- Pearson, A D
- Roché, H
- Robert, A
- Newell, D R
- Canal, P
Producer: 19960605
In:
Clinical pharmacology and therapeutics vol. 59
Availability: No items available.
|
|
|
104.
|
Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy. [electronic resource] by
- Veal, G J
- Dias, C
- Price, L
- Parry, A
- Errington, J
- Hale, J
- Pearson, A D
- Boddy, A V
- Newell, D R
- Tilby, M J
Producer: 20011018
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 7
Availability: No items available.
|
|
|
105.
|
The myelotoxicity of carboplatin is influenced by the time of its administration. [electronic resource] by
- Kerr, D J
- Lewis, C
- O'Neil, B
- Lawson, N
- Blackie, R G
- Newell, D R
- Boxall, F
- Cox, J
- Rankin, E M
- Kaye, S B
Producer: 19900314
In:
Hematological oncology vol. 8
Availability: No items available.
|
|
|
106.
|
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer. [electronic resource] by
- Millward, M J
- Newell, D R
- Yuen, K
- Matthews, J P
- Balmanno, K
- Charlton, C J
- Gumbrell, L
- Lind, M J
- Chapman, F
- Proctor, M
Producer: 19960117
In:
Cancer chemotherapy and pharmacology vol. 37
Availability: No items available.
|
|
|
107.
|
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481). [electronic resource] by
- Millward, M J
- Newell, D R
- Mummaneni, V
- Igwemezie, L N
- Balmanno, K
- Charlton, C J
- Gumbrell, L
- Lind, M J
- Chapman, F
- Proctor, M
Producer: 19960801
In:
European journal of cancer (Oxford, England : 1990) vol. 31A
Availability: No items available.
|
|
|
108.
|
|
|
|
109.
|
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. [electronic resource] by
- White, A W
- Almassy, R
- Calvert, A H
- Curtin, N J
- Griffin, R J
- Hostomsky, Z
- Maegley, K
- Newell, D R
- Srinivasan, S
- Golding, B T
Producer: 20001207
In:
Journal of medicinal chemistry vol. 43
Availability: No items available.
|
|
|
110.
|
|
|
|
111.
|
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. [electronic resource] by
- Newell, D R
- Pearson, A D
- Balmanno, K
- Price, L
- Wyllie, R A
- Keir, M
- Calvert, A H
- Lewis, I J
- Pinkerton, C R
- Stevens, M C
Producer: 19931223
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 11
Availability: No items available.
|
|
|
112.
|
Novel potent inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase (PARP). [electronic resource] by
- Griffin, R J
- Pemberton, L C
- Rhodes, D
- Bleasdale, C
- Bowman, K
- Calvert, A H
- Curtin, N J
- Durkacz, B W
- Newell, D R
- Porteous, J K
Producer: 19951212
In:
Anti-cancer drug design vol. 10
Availability: No items available.
|
|
|
113.
|
Carboplatin dosage: prospective evaluation of a simple formula based on renal function. [electronic resource] by
- Calvert, A H
- Newell, D R
- Gumbrell, L A
- O'Reilly, S
- Burnell, M
- Boxall, F E
- Siddik, Z H
- Judson, I R
- Gore, M E
- Wiltshaw, E
Producer: 19891207
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 7
Availability: No items available.
|
|
|
114.
|
Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines. [electronic resource] by
- Barnes, M J
- Estlin, E J
- Taylor, G A
- Aherne, G W
- Hardcastle, A
- McGuire, J J
- Calvete, J A
- Lunec, J
- Pearson, A D
- Newell, D R
Producer: 19991122
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 5
Availability: No items available.
|
|
|
115.
|
Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group Trial. [electronic resource] by
- Thomas, H
- Boddy, A V
- English, M W
- Hobson, R
- Imeson, J
- Lewis, I
- Morland, B
- Pearson, A D
- Pinkerton, R
- Price, L
- Stevens, M
- Newell, D R
Producer: 20001130
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 18
Availability: No items available.
|
|
|
116.
|
Probing the active site and mechanism of action of O6-methylguanine-DNA methyltransferase with substrate analogues (O6-substituted guanines). [electronic resource] by
- Arris, C E
- Bleasdale, C
- Calvert, A H
- Curtin, N J
- Dalby, C
- Golding, B T
- Griffin, R J
- Lunn, J M
- Major, G N
- Newell, D R
Producer: 19941216
In:
Anti-cancer drug design vol. 9
Availability: No items available.
|
|
|
117.
|
Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. [electronic resource] by
- Speth, P A
- Gore, M E
- Pateman, A J
- Newell, D R
- Bishop, J A
- Ellis, W J
- Green, J A
- Gumbrell, L A
- Linssen, P C
- Miller, A
Producer: 19880705
In:
Cancer chemotherapy and pharmacology vol. 21
Availability: No items available.
|
|
|
118.
|
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717). [electronic resource] by
- Calvert, A H
- Newell, D R
- Jackman, A L
- Gumbrell, L A
- Sikora, E
- Grzelakowska-Sztabert, B
- Bishop, J A
- Judson, I R
- Harland, S J
- Harrap, K R
Producer: 19880304
In:
NCI monographs : a publication of the National Cancer Institute no. 5
Availability: No items available.
|
|
|
119.
|
Quinazoline antifolates inhibiting thymidylate synthase: variation of the N10 substituent. [electronic resource] by
- Jones, T R
- Calvert, A H
- Jackman, A L
- Eakin, M A
- Smithers, M J
- Betteridge, R F
- Newell, D R
- Hayter, A J
- Stocker, A
- Harland, S J
Producer: 19851107
In:
Journal of medicinal chemistry vol. 28
Availability: No items available.
|
|
|
120.
|
Resistance-modifying agents. Part 7: 2,6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha1-acid glycoprotein (AGP). [electronic resource] by
- Barlow, H C
- Bowman, K J
- Curtin, N J
- Calvert, A H
- Golding, B T
- Huang, B
- Loughlin, P J
- Newell, D R
- Smith, P G
- Griffin, R J
Producer: 20000613
In:
Bioorganic & medicinal chemistry letters vol. 10
Availability: No items available.
|